Apollomics (APLM) Price/OCF Ratio: History & Chart

Apollomics, Inc.(APLM)

Biotechnology · Foster City, CA

$22.23-1.04 (-4.45%)

Delayed quote: Oct 6, 2026, 2:49 PM EDT

About Apollomics, Inc.

Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.

Foster City, CA

14 employees

www.apollomicsinc.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Hung-Wen Chen

View full financials

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Apollomics, Inc. (APLM)	$49.10M	N/A	N/A	N/A	N/A
TELA Bio, Inc. (TELA)vs ›	$49.21M	N/A	N/A	N/A	N/A
Microbot Medical Inc. (MBOT)vs ›	$49.44M	N/A	13.21	14.20	14.20
Precision Optics Corporation, Inc. (POCI)vs ›	$49.47M	N/A	73.59	628.92	487.62
Sensus Healthcare, Inc. (SRTS)vs ›	$49.55M	N/A	43.78	43.71	50.95
INmune Bio, Inc. (INMB)vs ›	$49.18M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$49.94M	N/A	N/A	N/A	N/A
Lite Strategy, Inc. (LITS)vs ›	$47.81M	N/A	N/A	N/A	N/A
Clene Inc. (CLNN)vs ›	$50.51M	N/A	N/A	N/A	N/A
Envoy Medical, Inc. (COCH)vs ›	$50.56M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

PRICE/OCF RATIO

TTM

Apollomics, Inc. (APLM)

$49.10M

N/A

TELA Bio, Inc. (TELA)vs ›

$49.21M

N/A

Microbot Medical Inc. (MBOT)vs ›

$49.44M

N/A

13.21

14.20

Precision Optics Corporation, Inc. (POCI)vs ›

$49.47M

N/A

73.59

628.92

487.62

Sensus Healthcare, Inc. (SRTS)vs ›

$49.55M

N/A

43.78

43.71

50.95

INmune Bio, Inc. (INMB)vs ›

$49.18M

N/A

Dogwood Therapeutics, Inc. (DWTX)vs ›

$49.94M

N/A

Lite Strategy, Inc. (LITS)vs ›

$47.81M

N/A

Clene Inc. (CLNN)vs ›

$50.51M

N/A

Envoy Medical, Inc. (COCH)vs ›

$50.56M

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Price/OCF Ratio: N/A

APLM Price/OCF Ratio Metrics

APLM Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics